ReviewPharmaceuticals (Basel, Switzerland)2023

Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma.

Emer Lynch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.